{ "id": "RL30790", "type": "CRS Report", "typeId": "REPORTS", "number": "RL30790", "active": false, "source": "EveryCRSReport.com, University of North Texas Libraries Government Documents Department", "versions": [ { "source": "EveryCRSReport.com", "id": 100257, "date": "2002-08-23", "retrieved": "2016-05-24T20:05:35.856941", "title": "The Andean Trade Preference Act: Background and Issues for Reauthorization", "summary": "Following passage by the 102nd Congress, President George Bush signed into law the Andean\nTrade\nPreference Act (ATPA) on December 4, 1991( P.L. 102-182 , title II), making it part of a multifaceted\nstrategy to counter illicit drug production and trade in Latin America. For ten years, it provided\npreferential, mostly duty-free, treatment to selected U.S. imports from Bolivia, Colombia, Ecuador,\nand Peru. ATPA's goal was to encourage growth of a more diversified Andean export base, thereby\npromoting development and providing an incentive for Andean farmers and other workers to pursue\neconomic alternatives to the drug trade.\n On December 4, 2001, ATPA expired and U.S. tariffs were reimposed on affected Andean\nexports. On February 15, 2002, the Bush Administration deferred collection of these tariffs for 90\ndays in expectation that the 107th Congress would either reauthorize ATPA or provide a short-term\nextension of its trade preferences. In part because the ATPA legislation was eventually linked to the\nlarger debate on trade promotion authority (TPA), Congress was unable to complete work on the bill\nbefore the deferral expired. The ATPA was eventually reauthorized as the Andean Trade Promotion\nand Drug Eradication Act (ATPDEA), Title XXXI of the Trade Act of 2002 ( H.R. 3009 ), which was signed into law by President Bush on August 6, 2002 ( P.L. 107-210 ). All duty\nreductions that were in place prior to ATPA's expiration were made retroactive to December 4, 2001\nand presumably all those duties collected are reimbursable.\n In evaluating the ATPA program, its trade effects were shown to have been relatively small,\nalthough there was some indication that the composition of trade changed and that, with a few\nproducts, a case could be made that ATPA supported this change. It is possible that the slightly\naltered composition of U.S. imports from ATPA countries reflected broader change in what Andean\ncountries were producing and that this in turn pointed to some indirect evidence that resources once\nused for drug-related activity were being redirected toward ATPA-eligible products. Isolating\nATPA's role from other counternarcotics and economic diversification programs, however, has been\na difficult challenge, producing imprecise estimates.\n Supporters of ATPA argued that its effects were evident and proposed that it be reauthorized\nto reinforce the U.S. commitment to the \"alternative development\" counternarcotics strategy and that\npreferential treatment be extended to other Andean exports to broaden the program's effects. In\ngeneral, the 107th Congress appeared to accept this position. To enhance the effects of ATPA, the\nreauthorization legislation provides for an extension of trade preferences through December 31,\n2006, extending them to cover exports previously excluded, including certain textile and apparel\narticles, canned tuna, watches and parts, petroleum, footwear, and selected leather bags and goods. \nCongress was also careful to consider, and in many cases preserve, the interests of domestic\nproducers. ATPA may be only a small part of a large and long-term counternarcotics effort, but\nCongress reasoned that expanding duty-free provisions of ATPA to include more exports in growth\nindustries may have a positive effect on the region.", "type": "CRS Report", "typeId": "REPORTS", "active": false, "formats": [ { "format": "HTML", "encoding": "utf-8", "url": "http://www.crs.gov/Reports/RL30790", "sha1": "68a69ef2a07ea6484ad124b7ae18ba496163752e", "filename": "files/20020823_RL30790_68a69ef2a07ea6484ad124b7ae18ba496163752e.html", "images": null }, { "format": "PDF", "encoding": null, "url": "http://www.crs.gov/Reports/pdf/RL30790", "sha1": "14b7884c8148808812ad1d7b88904a6b4d91f7c3", "filename": "files/20020823_RL30790_14b7884c8148808812ad1d7b88904a6b4d91f7c3.pdf", "images": null } ], "topics": [] }, { "source": "University of North Texas Libraries Government Documents Department", "sourceLink": "https://digital.library.unt.edu/ark:/67531/metacrs3537/", "id": "RL30790 2002-02-21", "date": "2002-02-21", "retrieved": "2005-06-12T11:47:53", "title": "The Andean Trade Preference Act: Background and Issues for Reauthorization", "summary": "On December 4, 1991, President George Bush signed into law the Andean Trade Preference Act (ATPA) to counter illicit drug production and trade in Latin America. For ten years, it has provided preferential, mostly duty-free, treatment of selected U.S. imports from Bolivia, Colombia, Ecuador, and Peru. The goal of ATPA is to encourage increased exports, thereby promoting development and providing an incentive for Andean farmers and other workers to pursue economic alternatives to the drug trade. This report discusses the ATPA, its background, and issues regarding its potential reauthorization.", "type": "CRS Report", "typeId": "REPORT", "active": false, "formats": [ { "format": "PDF", "filename": "files/20020221_RL30790_1e12fd00853095716c8a6aaec42973c9762cf070.pdf" }, { "format": "HTML", "filename": "files/20020221_RL30790_1e12fd00853095716c8a6aaec42973c9762cf070.html" } ], "topics": [ { "source": "LIV", "id": "Trade", "name": "Trade" }, { "source": "LIV", "id": "Tariff preferences", "name": "Tariff preferences" } ] }, { "source": "University of North Texas Libraries Government Documents Department", "sourceLink": "https://digital.library.unt.edu/ark:/67531/metacrs2013/", "id": "RL30790 2001-01-03", "date": "2001-01-03", "retrieved": "2005-06-12T11:46:51", "title": "The Andean Trade Preference Act: Background and Issues for Reauthorization", "summary": "On December 4, 1991, President George Bush signed into law the Andean Trade Preference Act (ATPA) to counter illicit drug production and trade in Latin America. For ten years, it has provided preferential, mostly duty-free, treatment of selected U.S. imports from Bolivia, Colombia, Ecuador, and Peru. The goal of ATPA is to encourage increased exports, thereby promoting development and providing an incentive for Andean farmers and other workers to pursue economic alternatives to the drug trade. This report discusses the ATPA, its background, and issues regarding its potential reauthorization.", "type": "CRS Report", "typeId": "REPORT", "active": false, "formats": [ { "format": "PDF", "filename": "files/20010103_RL30790_e51d606a5a41894086a64bf26cf07090592a9d7d.pdf" }, { "format": "HTML", "filename": "files/20010103_RL30790_e51d606a5a41894086a64bf26cf07090592a9d7d.html" } ], "topics": [ { "source": "LIV", "id": "Trade", "name": "Trade" }, { "source": "LIV", "id": "Tariff preferences", "name": "Tariff preferences" } ] } ], "topics": [ "Foreign Affairs" ] }